Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : OK100 Stem Cell
Therapeutic Area : Musculoskeletal
Study Phase : IND Enabling
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Celavet Inc. Plans Submission of Equine Tendinitis Study to FDA’s Center for Veterinary Medicine
Details : Celavet is submitting the study protocol to the CVM for Investigational New Animal Drug (INAD) status.
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Inapplicable
March 16, 2020
Lead Product(s) : OK100 Stem Cell
Therapeutic Area : Musculoskeletal
Highest Development Status : IND Enabling
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable